Tango Therapeutics TNGX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's enterprise value?
- Tango Therapeutics (TNGX) reported enterprise value of $2.86B in Q1 2026.
- How has Tango Therapeutics's enterprise value changed year-over-year?
- Tango Therapeutics's enterprise value increased by 2203.7% year-over-year, from $124.05M to $2.86B.
- What is the long-term trend for Tango Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), Tango Therapeutics's enterprise value has grown at a 2.0% compound annual growth rate (CAGR), from $1.01B to $1.11B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.